Page 2 of 4 FirstFirst 1234 LastLast
Results 11 to 20 of 32

Thread: Spinalon

  1. #11
    Quote Originally Posted by tomsonite View Post
    How could drugs activate spinal CPGs? Is it that the drugs simply allow the CPG to be more easily excited? Or do they expect people to take a drug and suddenly see a locomotor like response in the legs?
    tomsonsite, the central pattern generator CPG has receptors to neurotransmitters. Scientists have long known (like 50+ years) that it is possible to stimulate the CPG by injecting serotonin and other excitatory neurotransmitters intrathecally (into the cerebrospinal fluid surrounding the spinal cord). It has been a while since I looked at this trial but I assume that the spinalon combination is being injected intrathecally into patients with a pump (much like baclofen is injected but for shorter periods and under manual control, so that the person can apply the drug when walking is needed). One can of course stimulate the CPG electrically as well. Wise.

  2. #12
    Quote Originally Posted by scisucks View Post
    Hello all,

    Newbie here.

    Had a quick question re this - does the central pattern generator exist in those who have lumbar or sacral spinal injuries?
    Very good question. The CPG is believed to be located at L2 spinal cord. Note that the L1-S5 spinal cord is located between the T11-L1 vertebral spinal canal. The sacral spinal cord segments are located in the spinal canal for the L1 vertebral segment. Below L1, you only have the cauda equina or spinal roots.

    If you had a lower thoracic injury (i.e. T11, T12), you may have damaged the lumbar enlargement and the CPG. If you have a L1 or lower injury, your CPG may be intact.

    Wise.

  3. #13
    Quote Originally Posted by Wise Young View Post
    tomsonsite, the central pattern generator CPG has receptors to neurotransmitters. Scientists have long known (like 50+ years) that it is possible to stimulate the CPG by injecting serotonin and other excitatory neurotransmitters intrathecally (into the cerebrospinal fluid surrounding the spinal cord). It has been a while since I looked at this trial but I assume that the spinalon combination is being injected intrathecally into patients with a pump (much like baclofen is injected but for shorter periods and under manual control, so that the person can apply the drug when walking is needed). One can of course stimulate the CPG electrically as well. Wise.
    This study is a randomized, placebo-controlled, double-blind, single dose escalation study with fifty-one (51) patients who will receive either placebo capsules(starch) or capsules with buspirone only, levodopa/carbidopa only or buspirone/levodopa/carbidopa (SPINALON).

    http://clinicaltrials.gov/show/NCT01484184

  4. #14
    Quote Originally Posted by GRAMMY View Post
    This study is a randomized, placebo-controlled, double-blind, single dose escalation study with fifty-one (51) patients who will receive either placebo capsules(starch) or capsules with buspirone only, levodopa/carbidopa only or buspirone/levodopa/carbidopa (SPINALON).

    http://clinicaltrials.gov/show/NCT01484184
    Grammy,

    Thank you for correcting me. This is an oral drug. That is why I commented earlier about its possible effect on the heart and blood pressure. It will be interesting to see the results of the trial.

    Wise.

  5. #15

  6. #16
    Quote Originally Posted by Wise Young View Post
    tomsonsite, the central pattern generator CPG has receptors to neurotransmitters. Scientists have long known (like 50+ years) that it is possible to stimulate the CPG by injecting serotonin and other excitatory neurotransmitters intrathecally (into the cerebrospinal fluid surrounding the spinal cord). It has been a while since I looked at this trial but I assume that the spinalon combination is being injected intrathecally into patients with a pump (much like baclofen is injected but for shorter periods and under manual control, so that the person can apply the drug when walking is needed). One can of course stimulate the CPG electrically as well. Wise.
    Do CPG neurons respond to different neurotransmitters, or perhaps a specific combination of them, as opposed to other neurons? Or does the CPG act the way it does because of the neuronal "wiring", so to speak?

    Quote Originally Posted by GRAMMY View Post
    http://spinalcordresearchandadvocacy...dical-officer/

    Nordic Life Science Pipeline Inc. names new acting Chief Medical Officer


    They are planning to conduct a Spinalon phase II-B trial (expected for 2015) in US, Europe, Canada.
    I had forgotten about this trial, I wonder how it's going. Can they get approval to do a phase II trial without first completing the phase I? Or can they just send the FDA the results without having the study published first?

  7. #17
    Quote Originally Posted by tomsonite View Post
    Do CPG neurons respond to different neurotransmitters, or perhaps a specific combination of them, as opposed to other neurons? Or does the CPG act the way it does because of the neuronal "wiring", so to speak?

    I had forgotten about this trial, I wonder how it's going. Can they get approval to do a phase II trial without first completing the phase I? Or can they just send the FDA the results without having the study published first?
    http://www.jneurosci.org/content/33/2/734.full.pdf

    I believe the first trial was a 2 arm (Phase 1 and 2-A). The upcoming one would be a 2-B.

    The current trial on 51 people had this organization on it for the Phase 1 & 2A.
    The proposed study is a combination of 1 and 2-arm designs. First, a 2-arm design will be used, the first arm being composed of 3 subjects receiving the lowest dose of the study drug, and the second arm being composed of 1 subject receiving a placebo. This 2-arm design will be repeated consecutively (not simultaneously) with increasing doses of SPINALON, as long as the dose is well tolerated. Six (6) groups are expected to be tested with this 2-arm design.This will be followed by a 2-arm composed of 1 group with 1 subject receiving placebo and 1 larger group (10 subjects) who will receive SPINALON at MTD as identified in the previous 2-arm groups.
    Last edited by GRAMMY; 05-10-2014 at 12:56 AM.

  8. #18

  9. #19
    Senior Member marvin_cr's Avatar
    Join Date
    Mar 2005
    Location
    Des Moines, Iowa
    Posts
    100
    "This worldwide ground-breaking discovery enables preparation of the next step – that is even larger-scale studies (1000 patients) to seek approval for sales within 5 years in Canada, Europe and United States" Holy hell, still 5 yrs away. I will be dead in another three or four intervals of 5 yr

  10. #20
    Senior Member Tbone57's Avatar
    Join Date
    Jan 2012
    Location
    Staten Island, NY
    Posts
    153
    Another 2-3 five year intervals and I'll be dead also.

Similar Threads

  1. Spinalon
    By KIM in forum Cure
    Replies: 1
    Last Post: 08-10-2011, 09:51 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •